Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes

Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations ... Read More